Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for PT Multi Medika Internasional Tbk's Return-on-Tangible-Equity or its related term are showing as below:
ISX:MMIX's Return-on-Tangible-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 10.17 * Ranked among companies with meaningful Return-on-Tangible-Equity only.
PT Multi Medika Internasional Tbk (ISX:MMIX) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
PT Multi Medika Internasional Tbk Return-on-Tangible-Equity Related Terms
PT Multi Medika Internasional Tbk Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Multi Medika Internasional Tbk Return-on-Tangible-Equity Chart
PT Multi Medika Internasional Tbk Annual Data
Trend
Dec20
Dec21
Return-on-Tangible-Equity
0.00
180.50
PT Multi Medika Internasional Tbk Semi-Annual Data
Dec20
Dec21
Return-on-Tangible-Equity
0.00
180.50
PT Multi Medika Internasional Tbk Return-on-Tangible-Equity Competitor Comparison
For the Pharmaceutical Retailers subindustry, PT Multi Medika Internasional Tbk's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Multi Medika Internasional Tbk Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Multi Medika Internasional Tbk's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where PT Multi Medika Internasional Tbk's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is one times the annual (Dec. 2021) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 180.50% mean?
PT Multi Medika Internasional Tbk (ISX:MMIX) has a Return-on-Tangible-Equity of 180.50% as of Dec. 2021. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on PT Multi Medika Internasional Tbk and its competitors.
Is PT Multi Medika Internasional Tbk's Return-on-Tangible-Equity too high?
PT Multi Medika Internasional Tbk's current Return-on-Tangible-Equity is 180.50%. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.17. PT Multi Medika Internasional Tbk's value of 180.50% is 1674.8% above this industry median. Overall, PT Multi Medika Internasional Tbk has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does PT Multi Medika Internasional Tbk's Return-on-Tangible-Equity compare to competitors?
PT Multi Medika Internasional Tbk's Return-on-Tangible-Equity of 180.50% can be compared against companies in the Healthcare Providers & Services industry. The industry median Return-on-Tangible-Equity is 10.17. PT Multi Medika Internasional Tbk's value of 180.50% is 1674.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.17, based on 576 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Multi Medika Internasional Tbk's current Return-on-Tangible-Equity of 180.50% is 1674.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on PT Multi Medika Internasional Tbk and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Multi Medika Internasional Tbk's current Return-on-Tangible-Equity is 180.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Multi Medika Internasional Tbk stock overvalued right now?
PT Multi Medika Internasional Tbk (ISX:MMIX) has a current Return-on-Tangible-Equity of 180.50%. The current Return-on-Tangible-Equity is 180.50% and 1674.8% above the Healthcare Providers & Services industry median of 10.17. PT Multi Medika Internasional Tbk's overall GF Score™ is 24/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For PT Multi Medika Internasional Tbk (ISX:MMIX), the current Return-on-Tangible-Equity is 180.50% as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Multi Medika Internasional Tbk Business Description
PT Multi Medika Internasional Tbk is engaged in the wholesale trading of medical devices and pharmaceutical and laboratory equipment for humans, operating lease, and non-copyrighted works. It also wholesales other food and beverages, such as rice flour, tapioca flour, bakery premix, caramel, processed honey, shrimp crackers and others; agricultural food and beverages, such as herbs and spices; livestock and fisheries; non-alcoholic beverages, such as fruit juice, soft drinks, mineral water, bottled water, and other similar products; cosmetics for humans such as perfume, soap, powder and others. Its segments include Mask and other non food and beverages, and food and beverages. It derives the majoritf of the revenue from Mask and other non food and beverages segments.
24GF Score
Get the complete analysis for ISX:MMIX
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:MMIX has been successfully added to your 
